[1]
|
Dapas, M. and Dunaif, A. (2022) Deconstructing a Syndrome: Genomic Insights into PCOS Causal Mechanisms and Classification. Endocrine Reviews, 43, 927-965. https://doi.org/10.1210/endrev/bnac001
|
[2]
|
Manzano-Nunez, R., Santana-Dominguez, M., Rivera-Esteban, J., et al. (2023) Non-Alcoholic Fatty Liver Disease in Patients with Poly Cystic Ovary Syndrome: A Systematic Review, Meta-Analysis, and Meta-Regression. Journal of Clinical Medicine, 12, Article No. 856. https://doi.org/10.3390/jcm12030856
|
[3]
|
Palomba, S., Piltonen, T.T. and Giudice, L.C. (2021) Endometrial Function in Women with Poly Cystic Ovary Syndrome: A Comprehensive Review. Human Reproduction Update, 27, 584-618. https://doi.org/10.1093/humupd/dmaa051
|
[4]
|
Wu, J., Yao, X.-Y., Shi, R.-X., et al. (2018) A Potential Link between Poly Cystic Ovary Syndrome and Non-Alcoholic Fatty Liver Disease: An Update Meta-Analysis. Reproductive Health, 15, Article No. 77. https://doi.org/10.1186/s12978-018-0519-2
|
[5]
|
Liu, D., Gao, X., Pan, X.F., et al. (2023) The Hepato-Ovarian Axis: Genetic Evidence for a Causal Association between Non-Alcoholic Fatty Liver Disease and Poly Cystic Ovary Syndrome. BMC Medicine, 21, Article No. 62. https://doi.org/10.1186/s12916-023-02775-0
|
[6]
|
Arefhosseini, S., Ebrahimi-Mameghani, M., Najafipour, F., et al. (2022) Non-Alcoholic Fatty Liver Disease across Endocrinopathies: Interaction with Sex Hormones. Frontiers in Endocrinology (Lausanne), 13, Article ID: 1032361. https://doi.org/10.3389/fendo.2022.1032361
|
[7]
|
Shahbaz, M., Almatooq, H., Foucambert, P., et al. (2022) A Systematic Review of the Risk of Non-Alcoholic Fatty Liver Disease in Women with Poly Cystic Ovary Syndrome. Cureus, 14, E29928. https://doi.org/10.7759/cureus.29928
|
[8]
|
Eslami, B., Aletaha, N., Maleki-Hajiagha, A., et al. (2022) Evaluation of the Predictive Value of Body Mass Index (BMI), Waist Circumference, and Visceral Fat to Differentiate Non-Alcoholic Fatty Liver (MAFLD) in Women with Poly Cystic Ovary Syndrome. Journal of Research in Medical Sciences, 27, 37. https://doi.org/10.4103/jrms.JRMS_292_20
|
[9]
|
De Robertis, R., Spoto, F., Autelitano, D., et al. (2023) Ultrasound-Derived Fat Fraction for Detection of Hepatic Steatosis and Quantification of Liver Fat Content. Radiologia Medica, 128, 1174-1180. https://doi.org/10.1007/s11547-023-01693-8
|
[10]
|
Zalcman, M., Barth, R.A. and Rubesova, E. (2023) Real-Time Ultrasound-Derived Fat Fraction in Pediatric Population: Feasibility Validation with MR-PDFF. Pediatric Radiology, 53, 2466-2475. https://doi.org/10.1007/s00247-023-05752-0
|
[11]
|
Xia, T., Du, M., Li, H., et al. (2023) Association between Liver MRI Proton Density Fat Fraction and Liver Disease Risk. Radiology, 309, E231007. https://doi.org/10.1148/radiol.231007
|
[12]
|
Otaghi, M., Azami, M., Khorshidi, A., et al. (2019) The Association between Metabolic Syndrome and Poly Cystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2019, 1481-1489. https://doi.org/10.1016/j.dsx.2019.01.002
|
[13]
|
Varma, S.H., Tirupati, S., Pradeep, T., et al. (2019) Insulin Resistance and Hyperandrogenemia Independently Predict Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2019, 1065-1069. https://doi.org/10.1016/j.dsx.2018.12.020
|
[14]
|
Gu, J., Liu, S., Du, S., et al. (2019) Diagnostic Value of MRI-PDFF for Hepatic Steatosis in Patients with Non-Alcoholic Fatty Liver Disease: A Meta-Analysis. European Radiology, 29, 3564-3573. https://doi.org/10.1007/s00330-019-06072-4
|
[15]
|
Huffman, A.M. and Romero, D.G. (2022) Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome: A Race against the Clock. Endocrinology, 163, bqac167. https://doi.org/10.1210/endocr/bqac167
|
[16]
|
Dogan, K., Helvacioglu, C., Baghaki, S., et al. (2020) Comparison of Body Mass Index and Metabolic Parameters with Serum Vaspin Levels in Women with Polycystic Ovary Syndrome. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14, 137-139. https://doi.org/10.1016/j.dsx.2020.01.008
|
[17]
|
Castera, L., Friedrich-Rust, M. and Loomba, R. (2019) Noninvasive Assessment of Liver Disease in Patients with Nonalcoholic Fatty Liver Disease. Gastroenterology, 156, 1264-1281.E4. https://doi.org/10.1053/j.gastro.2018.12.036
|
[18]
|
Reeder, S.B., Cruite, I., Hamilton, G., et al. (2011) Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy. Journal of Magnetic Resonance Imaging, 34, 729-749. https://doi.org/10.1002/jmri.22580
|
[19]
|
Blukacz, Ł., Nowak, A., Wójtowicz, M., et al. (2022) Clinical Usefulness of Non-Invasive Metabolic-Associated Fatty Liver Disease Risk Assessment Methods in Patients with Full-Blown Poly Cystic Ovary Syndrome in Relation to the MRI Examination with the Ideal IQ Sequence. Biomedicines, 10, Article No. 2193. https://doi.org/10.3390/biomedicines10092193
|
[20]
|
Ferraioli, G., Raimondi, A., Maiocchi, L., et al. (2023) Liver Fat Quantification with Ultrasound: Depth Dependence of Attenuation Coefficient. Journal of Ultrasound in Medicine, 42, 2247-2255. https://doi.org/10.1002/jum.16242
|
[21]
|
Labyed, Y. and Milkowski, A. (2020) Novel Method for Ultrasound-Derived Fat Fraction Using an Integrated Phantom. Journal of Ultrasound in Medicine, 39, 2427-2438. https://doi.org/10.1002/jum.15364
|
[22]
|
Gao, J., Wong, C., Maar, M., et al. (2021) Reliability of Performing Ultrasound Derived SWE and Fat Fraction in Adult Livers. Clinical Imaging, 80, 424-429. https://doi.org/10.1016/j.clinimag.2021.08.025
|
[23]
|
Franz, D., Weidlich, D., Freitag, F., et al. (2018) Association of Proton Density Fat Fraction in Adipose Tissue with Imaging-Based and Anthropometric Obesity Markers in Adults. International Journal of Obesity (London), 42, 175-182. https://doi.org/10.1038/ijo.2017.194
|